Photocatalytic Activation Strategy for Sequential Prodrug Release to Overcome Resistant Biofilms
Abstract
Drug-resistant biofilms present a formidable therapeutic challenge by limiting the antibiotic penetration and enhancing bacterial tolerance. A rational approach is to first disperse the biofilm to sensitize the embedded bacteria, followed by efficient antibiotic-mediated eradication. Such precisely ordered sequential release is essential to synchronizing biofilm dispersion with bacterial killing, thereby maximizing therapeutic efficacy while minimizing infection spread. However, achieving temporally resolved, time-gated release of distinct therapeutic agents remains highly challenging, particularly within a single-component system. Here, we report a nanoconfined photocatalytic platform that enables the sequential release of nitric oxide (NO) and levofloxacin (LEV) from a single-component prodrug. This strategy ensures an initial NO-mediated downregulation of antibiotic-resistant gene expression and enhanced bacterial susceptibility, followed by LEV-mediated bacterial eradication. The synchronized therapeutic sequence achieved potent antibiofilm efficacy in diabetic mice infected with LEV-resistant Pseudomonas aeruginosa, resulting in biofilm eradication, accelerated wound closure, and attenuated inflammation. Beyond antibacterial therapy, this one-component sequential release paradigm establishes a generalizable strategy for temporally programmed delivery of chemotherapeutic, anti-inflammatory, or anesthetic agents, underscoring both its conceptual novelty and broad…
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.